Skip to content
OpenCapital
Get started

BioCryst Pharmaceuticals BCRX Cash ratio

Cash ratio at other companies

Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
0.2×-0.8×
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
0.5×+0.1×
ANI Pharmaceuticals logo
ANI PharmaceuticalsANIP
1.3×+0.6×
AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
6×+3.7×
BridgeBio Pharma logo
BridgeBio PharmaBBIO
1.1×-2.5×
PVL
Palvella TherapeuticsPVLA
22.6×+14.2×

Other financials

Income statement

See full
Revenue$156.4M+7.5%
Gross profit$151.0M+7.1%
Operating income-$701.6M-3,405%
Net income-$721.8M-2,255,763%
EPS (diluted)-$2.98—

Balance sheet

See full
Cash & equivalents$173.4M+62.2%
Total debt$411.8M+24.7%
Total equity-$553.8M-22.6%
Total assets$465.1M-3.1%

Cash flow

See full
Operating cash flow-$61.8M-125%
CapEx$403.0K+182%
Free cash flow-$62.2M-125%

Valuation

See full
Market cap$2.37B+52.3%
Enterprise value$2.6B+46.7%
P/S2.7×-0.4×

Profitability

See full
Gross margin97.8%+0.8pp
Operating margin-43.1%-49.7pp
Net margin-51.7%-69.7pp
FCF margin35%—

Returns & leverage

See full
Return on equity-882.8%—
Debt / equity0.1×—
Current ratio1.9×-1.0×

Where this comes from

Calculated from BioCryst Pharmaceuticals’s reported figures.

cash and equivalents/total current liabilities=0.9×

Based on the most recent quarter.

The official record: BioCryst Pharmaceuticals’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about BioCryst Pharmaceuticals's cash ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is BioCryst Pharmaceuticals's cash ratio?
BioCryst Pharmaceuticals (BCRX) reported cash ratio of 0.9× in Q1 2026.
How has BioCryst Pharmaceuticals's cash ratio changed year-over-year?
BioCryst Pharmaceuticals's cash ratio increased by 16.1% year-over-year, from 0.8× to 0.9×.
What is the long-term trend for BioCryst Pharmaceuticals's cash ratio?
Over 5 years (2020 to 2025), BioCryst Pharmaceuticals's cash ratio has grown at a -29.0% compound annual growth rate (CAGR), from 2.6× to 0.5×.
What does cash ratio mean?
Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.